Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand?
Background and objective: Genetic predisposition is a factor in 40–70% of cases of benign prostatic hyperplasia (BPH) and voiding symptoms. However, informal reviews summarizing genes and variants imparting genetic disposition to BPH are not yet available. Methods: We conducted an informal narrative...
Saved in:
Main Authors: | Martin Hennenberg, Sheng Hu, Alexander Tamalunas, Christian G. Stief |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | European Urology Open Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266616832401098X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
by: Mohamad Baker Berjaoui, et al.
Published: (2024-11-01) -
Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
by: Ansh Bhatia, et al.
Published: (2024-12-01) -
Analysis of risk factors for bladder neck contracture after transurethral endoscopic surgery for benign prostatic hyperplasia
by: Yingbing Wu, et al.
Published: (2024-12-01) -
Development of a Deep Learning-Based Predictive Model for Improvement after Holmium Laser Enucleation of the Prostate According to Detrusor Contractility
by: Jong Hoon Lee, et al.
Published: (2024-11-01) -
Clinical pathway interpretation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia
by: Si-Yu YAN, et al.
Published: (2022-06-01)